Skip to main content
SpringerLink
Log in

Complications tardives de la radiothérapie

  • Chapter
Aider á vivre aprés un cancer

Part of the book series: Oncologie pratique ((ONCOLPRAT))

  • 384 Accesses

Résumé

Le succés de la radiothérapie (RT) dépend principalement de la dose totale délivrée de maniére homogéne au niveau de la tumeur. Cependant, la délivrance de cette dose est limitée par la tolérance des tissus sains dans le volume irradié (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Emami B, Lyman J, Brown A, et al. (1991)Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21: 109–22

    Article  PubMed  CAS  Google Scholar 

  2. Withers HR, Taylor JM, Maciejewski B (1988)Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 14: 751–9

    Article  PubMed  CAS  Google Scholar 

  3. Buchholz TA (1999)Finding our sensitive patients. Int J Radiat Oncol Biol Phys 45: 547–8

    Article  PubMed  CAS  Google Scholar 

  4. Dubray B (1995)Late complications of radiotherapy. Role of the time factor. Bull Cancer Radiother 82: 98–100

    Article  PubMed  CAS  Google Scholar 

  5. Dubray B, Delanian S, Lefaix JL (1997)Late effects of mammary radiotherapy on skin and subcutaneous tissues. Cancer Radiother 1: 744–52

    Article  PubMed  CAS  Google Scholar 

  6. Lartigau E, Dubray B, Mornex F (1997)Biological mechanisms of late effects of ionizing radiations. Cancer Radiother 1: 669–76

    Article  PubMed  CAS  Google Scholar 

  7. Dubray B, Pavy JJ, Giraud P (1997)Predictive tests of response to radiotherapy. Assessment and perspectives in 1997. Cancer Radiother 1: 473–83

    Article  PubMed  CAS  Google Scholar 

  8. Stone HB, Coleman CN, Anscher MS, McBride WH (2003)Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 4: 529–36

    Article  PubMed  CAS  Google Scholar 

  9. Delanian S, Balla-Mekias S, Lefaix JL (1999)Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17: 3283–90

    PubMed  CAS  Google Scholar 

  10. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL (2003)Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superfi cial radiationinduced fi brosis. J Clin Oncol 21: 2545–50

    Article  PubMed  CAS  Google Scholar 

  11. Trotti A, Colevas AD, Setser A, et al. (2003)CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13: 176–81

    Article  PubMed  Google Scholar 

  12. Trotti A, Byhardt R, Stetz J, et al. (2000)Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47: 13–47

    Article  PubMed  CAS  Google Scholar 

  13. Denis F, Garaud P, Bardet E, et al. (2003)Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55: 93–8

    Article  PubMed  Google Scholar 

  14. Thames HD, Hendry JH, Moore JV, et al. (1989)The high steepness of dose-response curves for late-responding normal tissues. Radiother Oncol 15: 49–53

    Article  PubMed  CAS  Google Scholar 

  15. Huchet A, Caudry M, Belkacemi Y, et al. (2003)Volume-effect and radiotherapy (II). Part II: volume-effect and normal tissue. Cancer Radiother 7: 353–62

    Article  PubMed  CAS  Google Scholar 

  16. Cesaretti JA, Stock RG, Lehrer S, et al. (2005)ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 61: 196–202

    Article  PubMed  Google Scholar 

  17. Iannuzzi CM, Atencio DP, Green S (2002)ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52: 606–13

    Article  PubMed  CAS  Google Scholar 

  18. Azria D, Gourgou S, Sozzi WJ, et al. (2004)Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fi brosis in hypersensitive patients. Br J Cancer 91: 1251–60

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  19. Azria D, Ozsahin M, Gligorov J, et al. (2008)How to combine hormonotherapy and radiation treatment in adjuvant breast cancer? Cancer Radiother 12: 37–41

    Article  PubMed  CAS  Google Scholar 

  20. Azria D, Ozsahin M, Kramar A, et al. (2008)Single nucleotide polymorphisms, apoptosis and the development of severe late adverse effects following radiotherapy. Clin Cancer Res 14: 6284–8

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Radford IR, Murphy TK (1994)Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may infl uence sensitivity to killing by DNA double-strand breakage. Int J Radiat Biol 65: 229–39

    Article  PubMed  CAS  Google Scholar 

  22. Trowell OA (1952)The sensitivity of lymphocytes to ionising radiation. J Pathol Bacteriol 64: 687–704

    Article  PubMed  CAS  Google Scholar 

  23. Crompton NE, Ozsahin M (1997)A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat Res 147: 55–60

    Article  PubMed  CAS  Google Scholar 

  24. Ozsahin M, Ozsahin H, Shi Y, et al. (1997)Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys 38: 429–40

    Article  PubMed  CAS  Google Scholar 

  25. Dewey WC, Ling CC, Meyn RE (1995)Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33: 781–96

    Article  PubMed  CAS  Google Scholar 

  26. Floyd DN, Cassoni AM (1994)Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleus assay. Eur J Cancer 30: 615–20

    Article  Google Scholar 

  27. Hoeller U, Borgmann K, Bonacker M, et al. (2003)Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fi brosis after radiotherapy for breast cancer. Radiother Oncol 69: 137–44

    Article  PubMed  Google Scholar 

  28. Johansen J, Bentzen SM, Overgaard J, Overgaard M (1996)Relationship between the in vitro radiosensitivity of skin fi broblasts and the expression of subcutaneous fi brosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 40: 101–9

    Article  PubMed  CAS  Google Scholar 

  29. Kiltie AE, Ryan AJ, Swindell R, Barber JB, et al. (1999)A correlation between residual radiation-induced DNA double-strand breaks in cultured fi broblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol 51: 55–65

    Article  PubMed  CAS  Google Scholar 

  30. Crompton NE, Shi YQ, Emery GC, et al. (2001) Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 49: 547–54

    Article  PubMed  CAS  Google Scholar 

  31. Slonina D, Gasinska A (1997)Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J Radiat Biol 72: 693–701

    Article  PubMed  CAS  Google Scholar 

  32. Ozsahin M, Crompton NE, Gourgou S, et al. (2005)CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 11: 7426–33

    Article  PubMed  CAS  Google Scholar 

  33. Azria D, Rosenstein BS, Ozsahin M (2008)Radiation-induced side-effects with or without systemic therapies: Primetime for prediction of individual radiosensitivity! Int J Radiat Oncol Biol Phys 71: 1293–4

    Article  PubMed  Google Scholar 

  34. Ho AY, Atencio DP, Peters S, et al. (2006)Genetic predictors of adverse radiotherapy effects: the gene-PARE project. Int J Radiat Oncol Biol Phys 65: 646–55

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département d’oncologie radiothérapie INSERM U896, CRLC Val d’Aurelle-Paul-Lamarque, 34298, Montpellier Cedex 5

    David Azria

  2. Service de radiothérapie, CHU Vaudois, Bugnon 46, CH-1011, Lausanne

    Mahmut Ozsahin

Authors
  1. David Azria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahmut Ozsahin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France

About this chapter

Cite this chapter

Azria, D., Ozsahin, M. (2010). Complications tardives de la radiothérapie. In: Aider á vivre aprés un cancer. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-79501-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-79501-5_16

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-79500-8

  • Online ISBN: 978-2-287-79501-5

Publish with us

Policies and ethics

Search

Navigation